tiprankstipranks
Creo Medical Group PLC (GB:CREO)
LSE:CREO

Creo Medical (CREO) Financial Statements

11 Followers

Creo Medical Financial Overview

Creo Medical's market cap is currently ―. The company's EPS TTM is p-0.115; its P/E ratio is -3.23; Creo Medical is scheduled to report earnings on September 26, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 26.10M£ 43.53M£ 30.55M£ 45.09M£ 70.63M
Total Assets£ 87.50M£ 100.61M£ 80.63M£ 92.46M£ 79.86M
Total Debt£ 12.06M£ 10.56M£ 10.73M£ 12.36M£ 918.54K
Net Debt£ -14.04M£ -32.98M£ -19.82M£ -32.74M£ -69.71M
Total Liabilities£ 26.40M£ 27.29M£ 28.38M£ 29.66M£ 5.68M
Stockholders Equity£ 61.10M£ 73.32M£ 52.25M£ 62.81M£ 74.19M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Creo Medical Earnings and Revenue History

Creo Medical Debt to Assets

Creo Medical Cash Flow

Creo Medical Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis